409
Views
28
CrossRef citations to date
0
Altmetric
Original Research

Efficacy and safety of prolonged-release melatonin in insomnia patients with diabetes: a randomized, double-blind, crossover study

, , , , &
Pages 307-313 | Published online: 02 Aug 2011

References

  • Narayan KM Gregg EW Fagot-Campagna A Engelgau MM Vinicor F Diabetes: a common, growing, serious, costly, and potentially preventable public health problem Diabetes Res Clin Pract 2000 50 Suppl 2 S77 S84 11024588
  • Foley DJ Monjan A Simonsick EM Wallace RB Blazer DG Incidence and remission of insomnia among elderly adults: an epidemiologic study of 6,800 persons over three years Sleep 1999 22 Suppl 2 S366 S372 10394609
  • Chasens ER Understanding sleep in persons with diabetes Diabetes Educ 2007 33 3 435 436 17570874
  • Gottlieb DJ Punjabi NM Newman AB Association of sleep time with diabetes mellitus and impaired glucose tolerance Arch Intern Med 2005 165 8 863 867 15851636
  • Barone MT Menna-Barreto L Diabetes and sleep: a complex cause-and-effect relationship Diabetes Res Clin Pract 2011 91 2 129 137 20810183
  • Knutson KL Van Cauter E Zee P Liu K Lauderdale DS Cross-sectional associations between measures of sleep and markers of glucose metabolism among subjects with and without diabetes: the Coronary Artery Risk Development in Young Adults (CARDIA) Sleep Study Diabetes Care 2011 34 5 1171 1176 21411507
  • Eriksson AK Ekbom A Granath F Hilding A Efendic S Ostenson CG Psychological distress and risk of pre-diabetes and type 2 diabetes in a prospective study of Swedish middle-aged men and women Diabet Med 2008 25 7 834 842 18513304
  • Cajochen C Krauchi K Wirz-Justice A Role of melatonin in the regulation of human circadian rhythms and sleep J Neuroendocrinol 2003 15 4 432 437 12622846
  • Gorfine T Assaf Y Goshen-Gottstein Y Yeshurun Y Zisapel N Sleep-anticipating effects of melatonin in the human brain Neuroimage 2006 31 1 410 418 16427787
  • Gorfine T Zisapel N Late evening brain activation patterns and their relation to the internal biological time, melatonin, and homeostatic sleep debt Hum Brain Mapp 2009 30 2 541 552 18095278
  • Sharma M Palacios-Bois J Schwartz G Circadian rhythms of melatonin and cortisol in aging Biol Psychiatry 1989 25 3 305 319 2914154
  • Leger D Laudon M Zisapel N Nocturnal 6-sulfatoxymelatonin excretion in insomnia and its relation to the response to melatonin replacement therapy Am J Med 2004 116 2 91 95 14715322
  • O’Brien IA Lewin IG O’Hare JP Arendt J Corrall RJ Abnormal circadian rhythm of melatonin in diabetic autonomic neuropathy Clin Endocrinol (Oxf) 1986 24 4 359 364 3742831
  • Sandyk R Anastasiadis PG Anninos PA Tsagas N Is the pineal gland involved in the pathogenesis of endometrial carcinoma Int J Neurosci 1992 62 1–2 89 96 1342018
  • Zisapel N Sleep and sleep disturbances: biological basis and clinical implications Cell Mol Life Sci 2007 64 10 1174 1186 17364142
  • Nishida S Metabolic effects of melatonin on oxidative stress and diabetes mellitus Endocrine 2005 27 2 131 136 16217126
  • Korkmaz A Reiter RJ Topal T Manchester LC Oter S Tan DX Melatonin: an established antioxidant worthy of use in clinical trials Mol Med 2009 15 1–2 43 50 19011689
  • Peschke E Melatonin, endocrine pancreas and diabetes J Pineal Res 2008 44 1 26 40 18078445
  • Robeva R Kirilov G Tomova A Kumanov P Melatonin-insulin interactions in patients with metabolic syndrome J Pineal Res 2008 44 1 52 56 18078448
  • Prokopenko I Langenberg C Florez JC Variants in MTNR1B influence fasting glucose levels Nat Genet 2009 41 1 77 81 19060907
  • Tam CH Ho JS Wang Y Common polymorphisms in MTNR1B, G6PC2 and GCK are associated with increased fasting plasma glucose and impaired beta-cell function in Chinese subjects PLoS One 2010 5 7 e11428 20628598
  • Mussig K Staiger H Machicao F Haring HU Fritsche A Genetic variants in MTNR1B affecting insulin secretion Ann Med 2010 42 6 387 393 20597807
  • Waldhauser F Waldhauser M Lieberman HR Deng MH Lynch HJ Wurtman RJ Bioavailability of oral melatonin in humans Neuroendocrinology 1984 39 4 307 313 6493445
  • Wade A Downie S Prolonged-release melatonin for the treatment of insomnia in patients over 55 years Expert Opin Investig Drugs 2008 17 10 1567 1572
  • Luthringer R Muzet M Zisapel N Staner L The effect of prolonged-release melatonin on sleep measures and psychomotor performance in elderly patients with insomnia Int Clin Psychopharmacol 2009 24 5 239 249 19584739
  • Wade AG Ford I Crawford G Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety BMC Med 2010 8 51 20712869
  • Wade AG Crawford G Ford I Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response Curr Med Res Opin 2011 27 1 87 98 21091391
  • Garfinkel D Laudon M Nof D Zisapel N Improvement of sleep quality in elderly people by controlled-release melatonin Lancet 1995 346 8974 541 544 7658780
  • Coniff RF Shapiro JA Robbins D Reduction of glycosylated hemoglobin and postprandial hyperglycemia by acarbose in patients with NIDDM. A placebo-controlled dose-comparison study Diabetes Care 1995 18 6 817 824 7555508
  • Wrist activity based monitoring of nocturnal sleep: validation of a novel scoring algorithm. Ninth annual meeting of the Associated Professional Sleep Societies, Nashville, TE 1995
  • Cagnacci A Arangino S Renzi A Influence of melatonin administration on glucose tolerance and insulin sensitivity of post-menopausal women Clin Endocrinol (Oxf) 2001 54 3 339 346 11298086
  • Hussain SA Khadim HM Khalaf BH Ismail SH Hussein KI Sahib AS Effects of melatonin and zinc on glycemic control in type 2 diabetic patients poorly controlled with metformin Saudi Med J 2006 27 10 1483 1488 17013468
  • Nishida S Segawa T Murai I Nakagawa S Long-term melatonin administration reduces hyperinsulinemia and improves the altered fatty-acid compositions in type 2 diabetic rats via the restoration of delta-5 desaturase activity J Pineal Res 2002 32 1 26 33 11841597
  • Radziuk J Pye S Diurnal rhythm in endogenous glucose production is a major contributor to fasting hyperglycaemia in type 2 diabetes. Suprachiasmatic deficit or limit cycle behaviour? Diabetologia 2006 49 7 1619 1628 16752180
  • Lenters-Westra E Slingerland RJ Hemoglobin A1c point-of-care assays; a new world with a lot of consequences! J Diabetes Sci Technol 2009 3 3 418 423 20144277
  • Stratton IM Adler AI Neil HA Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study BMJ 2000 321 7258 405 412 10938048